Navigation Links
Heart disease starts early

Risk factors such as insulin resistance and high blood pressure begin as early as age 15, according to a recent study. Researchers measured obesity, insulin resistance, blood pressure and cholesterol levels of 267 boys and girls. Measurements were taken when the young people were 13 and again when they were 15. Obesity levels were measured using a body mass index (BMI) calculation. BMI is the person's weight in kilograms divided by their height in meters squared (wt/ht2). Researchers classified those with a BMI of 25 or greater as overweight while those with a BMI of 30 or greater were considered obese. Cholesterol and triglycerides were measured with a total cholesterol blood test, including levels of HDL (good) cholesterol, LDL (bad) cholesterol and triglycerides.//

Insulin resistance was measured through a process called an insulin clamp study. Participants were given a steady infusion on insulin through an IV, along with enough glucose to maintain safe body levels. The dose of the insulin was "clamped," meaning that it was held at a certain amount. Researchers then measured the amount of glucose needed. Lower amounts of glucose processed by the body indicated insulin resistance. At the time of the second measurements, researchers found a significant correlation between insulin resistance and systolic blood pressure in the boys. Systolic blood pressure is the top number in a blood pressure reading. This measurement represents the highest level of the blood's pressure within the artery walls and corresponds to the contraction of the heart's main pumping chambers (ventricles). Higher insulin resistance was related to a higher systolic blood pressure in the the15-year-old boys.

Researchers also found that insulin resistance in adolescents was linked to a decrease of "good" HDL cholesterol and an increase of triglycerides. In addition, the correlation between high blood pressure and insulin resistance was directly affected by levels of o
'"/>




Page: 1 2

Related medicine news :

1. One in Three Heart Attack Patients Have No Chest Pains
2. Epileptic Seizures Can Be Due to Heart Problem
3. Bypass Heart Surgery Performed Without General Anesthesia
4. New CPR Guidelines issued by Heart Association
5. White Cells Count Can Predict Heart Attack Death Risk
6. Vitamins-The answer to Heart Disease?
7. Fight Heart disease and Pain with Meditation
8. Heart disease in the newborn is related to maternal malnutrition
9. New drug to treat Heart Attack and damaged tissue
10. Heart disease threat starts early in life for Diabetics
11. Mechanical Heart
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Heart disease starts early

(Date:5/15/2008)...5 /PRNewswire-FirstCall/ -- Lung cancer patients,w...s may fare better as a,result, according to data f...linical trial. Data from the trial, which involved... injection), will be presented at the 44th Annual,...gy (ASCO) in Chicago,Ill., May 30 -- June 3, 2008...
(Date:5/15/2008)...h the goal of tailoring cancer treatment for each ...edical Center today presented a study suggesting a...assess treatment efficacy for patients with metast...and sometimes months to determine if a particular ...at long to observe any significant radiographic ch...
(Date:5/15/2008)...coxib, the anti-inflammatory medication also known... and reduces a specific proliferation measurement ...a study from The University of Texas M. D. Anderso...nificance of COX-2 inhibition toward preventing lu...ing the disease. , The study is the first large ...
(Date:5/15/2008)... 15 /Xinhua-PRNewswire-FirstCall/ -- Genesis,Pharm...GTEC) ("Genesis" or,the "Company"), a U.S. pharmac...he People,s Republic of China, today announced its... 2008, the Company,s third quarter of its,fiscal y...r the quarter,with the U.S. Securities Exchange Co...
Breaking Medicine News(10 mins):Health News:ASCO Study Confirms Importance of Histology in Treatment of Non-Small Cell Lung Cancer With ALIMTA (pemetrexed for injection) 2Health News:ASCO Study Confirms Importance of Histology in Treatment of Non-Small Cell Lung Cancer With ALIMTA (pemetrexed for injection) 3Health News:ASCO Study Confirms Importance of Histology in Treatment of Non-Small Cell Lung Cancer With ALIMTA (pemetrexed for injection) 4Health News:ASCO Study Confirms Importance of Histology in Treatment of Non-Small Cell Lung Cancer With ALIMTA (pemetrexed for injection) 5Health News:ASCO Study Confirms Importance of Histology in Treatment of Non-Small Cell Lung Cancer With ALIMTA (pemetrexed for injection) 6Health News:ASCO Study Confirms Importance of Histology in Treatment of Non-Small Cell Lung Cancer With ALIMTA (pemetrexed for injection) 7Health News:Study suggests blood test can help improve treatment outcomes for breast cancer patients 2Health News:Celebrex shows benefit in first-of-its-kind lung cancer chemoprevention trial 2Health News:Celebrex shows benefit in first-of-its-kind lung cancer chemoprevention trial 3Health News:Genesis Pharmaceuticals Reports Results for the Third Quarter of Fiscal Year 2008 2Health News:Genesis Pharmaceuticals Reports Results for the Third Quarter of Fiscal Year 2008 3Health News:Genesis Pharmaceuticals Reports Results for the Third Quarter of Fiscal Year 2008 4Health News:Genesis Pharmaceuticals Reports Results for the Third Quarter of Fiscal Year 2008 5Health News:Genesis Pharmaceuticals Reports Results for the Third Quarter of Fiscal Year 2008 6Health News:Genesis Pharmaceuticals Reports Results for the Third Quarter of Fiscal Year 2008 7Health News:Genesis Pharmaceuticals Reports Results for the Third Quarter of Fiscal Year 2008 8Health News:Genesis Pharmaceuticals Reports Results for the Third Quarter of Fiscal Year 2008 9Health News:Genesis Pharmaceuticals Reports Results for the Third Quarter of Fiscal Year 2008 10Health News:Genesis Pharmaceuticals Reports Results for the Third Quarter of Fiscal Year 2008 11Health News:Genesis Pharmaceuticals Reports Results for the Third Quarter of Fiscal Year 2008 12
...r Medco Health solutions Inc. claims that parents ...he drugs themselves. // The study examined the pre...ast year. The study also found that if one twin i...ly that the other would also take it than non-twin...
...cine that it says can ward off common allergies su...e by Cytos Biotechnology has been tested on humans...n the TB bug, reported the online edition of Daily...doubled in the past 20 years, with the condition a...
...ocacy group, Families USA, suggests that majority ... have at least one parent employed full-time//. An...be earning members. The group's executive directo...eve these are low-income people who don't work, wh...
...ple suffering a severe personality disorder are po...ealth Services are putting their best foot forward...959 Mental Health Act has indicated that chronical...stay in Mental Healthcare Hospitals, if their illn...
Other Medicine News:
(Date:5/15/2008)...tion Most Affected by Disease -, WAYNE, N.J. and ...--,Bayer HealthCare Pharmaceuticals, Inc. and Onyx...unced that Nexavar(R) (sorafenib) tablets,signific...R=0.68;,p-value=0.014) in patients in the Asia-Pac... (HCC), or primary liver cancer versus those,recei...
(Date:5/15/2008)...all/ -- Medivation, Inc.,(Nasdaq: MDVN ) today an...al,trial of its novel androgen receptor antagonist...on at the 44th American Society of Clinical Oncolo...itle: New Targeted Strategies for Patients with Pr... 2 at 11:30 a.m. Central Time Abstract title: "Ph...
(Date:5/15/2008)...eptable Tolerability Profile, with Low... LAKE, N.J., May 15 /- The investigat...389) demonstrated activity in a,heavily pretreated...static,breast cancer, according to results of a mu... suggests that eribulin mesylate has a manageable,...
(Date:5/15/2008)...stCall/ -- Schering-Plough,Corporation (NYSE: SGP...t of,chronic hepatitis C virus (HCV) infection, an...ies with PEGINTRON(TM) (peginterferon alfa-2b) and...as well as boceprevir, the,company,s investigation...at,the 39th annual Digestive Disease Week (DDW) me...
Breaking Medicine Technology:Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 2Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 3Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 4Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 5Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 6Medivation Announces Presentation of MDV3100 Clinical Data in Patients With Castration-Resistant Prostate Cancer at 44th American Society of Clinical Oncology Annual Meeting 2Medivation Announces Presentation of MDV3100 Clinical Data in Patients With Castration-Resistant Prostate Cancer at 44th American Society of Clinical Oncology Annual Meeting 3Eribulin Mesylate Demonstrated Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Breast Cancer 2Eribulin Mesylate Demonstrated Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Breast Cancer 3Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 2Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 3Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 4Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 5Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 6Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 7Breast cancer more aggressive among obese women 14374 1Breast cancer more aggressive among obese women 14374 2Physicists discover how fundamental particles lose track of quantum mechanical properties 3966 1Physicists discover how fundamental particles lose track of quantum mechanical properties 3966 2Physicists discover how fundamental particles lose track of quantum mechanical properties 3966 3MannKind to Present at the Cowen and Company Healthcare Conference 14372 1Dont Prescribe Antibiotics for Adult Sinus Woes 14369 1Dont Prescribe Antibiotics for Adult Sinus Woes 14369 2Dont Prescribe Antibiotics for Adult Sinus Woes 14369 3Dont Prescribe Antibiotics for Adult Sinus Woes 14369 4
...RK, April 10, 2007 /PRNewswire-FirstCall/ -- ImClo...ompany today,announced that a Phase III study of E...rapy) in patients with locally advanced,unresectab...s,primary endpoint of improving overall survival. ..., a cancer,center network sponsored by the Nationa...
...0 Shown to Be Well Tolerated and Potentially Suite...April 10, 2007 /PRNewswire-FirstCall/ --,Pharmacop...t of,novel small molecule therapeutics, today anno...inical trial of PS433540, the company,s,lead inter...nsion,and diabetic nephropathy. Data from the sing...
Other Medicine Technology:Data Available from Erbitux Phase III Study in First-Line Treatment,of Advanced Pancreatic Cancer 2Data Available from Erbitux Phase III Study in First-Line Treatment,of Advanced Pancreatic Cancer 3Data Available from Erbitux Phase III Study in First-Line Treatment,of Advanced Pancreatic Cancer 4Data Available from Erbitux Phase III Study in First-Line Treatment,of Advanced Pancreatic Cancer 5Data Available from Erbitux Phase III Study in First-Line Treatment,of Advanced Pancreatic Cancer 6Data Available from Erbitux Phase III Study in First-Line Treatment,of Advanced Pancreatic Cancer 7Data Available from Erbitux Phase III Study in First-Line Treatment,of Advanced Pancreatic Cancer 8Data Available from Erbitux Phase III Study in First-Line Treatment,of Advanced Pancreatic Cancer 9Pharmacopeia Announces Positive Results from Initial DARA Clinical,Trial 2Pharmacopeia Announces Positive Results from Initial DARA Clinical,Trial 3Pharmacopeia Announces Positive Results from Initial DARA Clinical,Trial 4Pharmacopeia Announces Positive Results from Initial DARA Clinical,Trial 5
Liquichek Unassayed Chemistry Control (Human) is a comprehensive, stable, liquid product designed to monitor general and special chemistry tests.
Lyphochek Assayed Chemistry Control requires no special diluent and has good reconstituted stability for enzymes and CO2. It is assayed for most major instruments and methodologies.
Liquichek Therapeutic Drug Monitoring Control (TDM) is a liquid assayed control containing a comprehensive menu of therapeutic drugs, as well as many common ligands. Available in three levels.
Lyphochek Urine Metals Control incorporates two levels of critical trace elements, heavy metals and organic metabolites, and is ideal for environmental and industrial testing.
Medicine Products: